| Name | Amylin |
|---|---|
| Synonyms | AMYLIN; IAP; DAP; Diabetes associated peptide; IAPP; Insulinoma amyloid peptide; Islet amyloid polypeptide; Islet amyloid polypeptide precursor… |
| Name | MAA |
|---|---|
| CAS | methylarsonic acid |
| PubMed | Abstract | RScore(About this table) | |
|---|---|---|---|
| 12534323 | : Pramlintide: (AC 137, AC 0137, Symlin, Tripro-Amylin). . BioDrugs. 2003;17(1):73-9. |
15(0,0,0,15) | Details |
| 11763160 | Barlocco D: Pramlintide (Amylin). . Curr Opin Investig Drugs. 2001 Nov;2(11):1575-81. In May 2001, Amylin submitted an MAA for pramlintide to the EMEA [411323] and in October 2001, Amylin received an approvable letter from the FDA for both Type I and insulin-using Type II diabetes; however, at this time, discussions with the FDA were ongoing regarding additional clinical work that was required before the NDA would be approved [425570]. |
9(0,0,1,4) | Details |